ABSTRACT

Examines harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations as they apply to human drug and device development, research, manufacturing, and marketing. The Second Edition focuses on the new drug approval process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements. Written in a jargon-free style, it draws information from a wide range of resources. It demystifies the inner workings of the FDA and facilitates an understanding of how it operates with respect to compliance and product approval.FDA Regulatory Affairs:provides a blueprint to the FDA and drug, biologic, and medical device developmentoffers current, real-time information in a simple and concise formatcontain

chapter 2|36 pages

What Is an IND?

chapter 4|16 pages

Meeting with the FDA

chapter 5|42 pages

FDA Medical Device Regulation

chapter 6|20 pages

The Development of Orphan Drugs

chapter 14|18 pages

Biologics